Study Status: COMPLETED
Recruit Status: COMPLETED
Study Type: INTERVENTIONAL
Official Title: Open-Label Roll-Over Study to Assess the Long-Term Safety and Efficacy of Ruxolitinib in Subjects With Myelofibrosis
Brief Summary: This phase II trial studies the long-term side effects of ruxolitinib in treating patients with myelofibrosis.
Collecting data about the long-term safety and tolerability of ruxolitinib may better help future patients with myelofibrosis.